Literature DB >> 24277326

Indicators for cognitive performance and subjective cognitive complaints in multiple sclerosis: a role for advanced MRI?

Hanneke E Hulst1, Karin Gehring2, Bernard Mj Uitdehaag3, Leo H Visser4, Chris H Polman3, Frederik Barkhof5, Margriet M Sitskoorn2, Jeroen Jg Geurts6.   

Abstract

Previous studies showed that advanced neuroimaging measures (functional MRI, diffusion tensor imaging) could distinguish multiple sclerosis (MS) patients with and without cognitive impairment. Are these measures indeed better indicators for cognitive impairment or subjective cognitive complaints than conventional MRI? Fifty MS patients and 29 controls were investigated. Regression analysis, including socio-demographic data, disease characteristics, psychological measures, and (advanced) neuroimaging, showed that worse cognitive performance was associated with male sex, lower education, and lower gray matter volume. Subjective cognitive complaints were associated with fatigue and less hippocampal atrophy. Advanced MRI measures did not add to the predictive power of our model.
© The Author(s) 2013.

Entities:  

Keywords:  MRI; atrophy; cognition; multiple sclerosis

Mesh：

Year:  2013        PMID： 24277326     DOI： 10.1177/1352458513513969

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


  7 in total

1.  Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma.

Authors:  Karin Gehring; Martin J B Taphoorn; Margriet M Sitskoorn; Neil K Aaronson
Journal:  Neurooncol Pract       Date:  2015-03-03

2.  The role of sleep on cognition and functional connectivity in patients with multiple sclerosis.

Authors:  Quinten van Geest; B Westerik; Y D van der Werf; J J G Geurts; H E Hulst
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

3.  Identification of Cortical and Subcortical Correlates of Cognitive Performance in Multiple Sclerosis Using Voxel-Based Morphometry.

Authors:  Jordi A Matías-Guiu; Ana Cortés-Martínez; Paloma Montero; Vanesa Pytel; Teresa Moreno-Ramos; Manuela Jorquera; Miguel Yus; Juan Arrazola; Jorge Matías-Guiu
Journal:  Front Neurol       Date:  2018-10-29       Impact factor: 4.003

4.  The Contribution of Various MRI Parameters to Clinical and Cognitive Disability in Multiple Sclerosis.

Authors:  Eszter Tóth; Péter Faragó; András Király; Nikoletta Szabó; Dániel Veréb; Krisztián Kocsis; Bálint Kincses; Dániel Sandi; Krisztina Bencsik; László Vécsei; Zsigmond Tamás Kincses
Journal:  Front Neurol       Date:  2019-01-23       Impact factor: 4.003

5.  Cognitive clinico-radiological paradox in early stages of multiple sclerosis.

Authors:  Tomas Uher; Jan Krasensky; Lukas Sobisek; Jana Blahova Dusankova; Zdenek Seidl; Eva Kubala Havrdova; Maria Pia Sormani; Dana Horakova; Tomas Kalincik; Manuela Vaneckova
Journal:  Ann Clin Transl Neurol       Date:  2017-12-15       Impact factor: 4.511

6.  Cognitive rehabilitation and mindfulness in multiple sclerosis (REMIND-MS): a study protocol for a randomised controlled trial.

Authors:  Ilse M Nauta; Anne E M Speckens; Roy P C Kessels; Jeroen J G Geurts; Vincent de Groot; Bernard M J Uitdehaag; Luciano Fasotti; Brigit A de Jong
Journal:  BMC Neurol       Date:  2017-11-21       Impact factor: 2.474

7.  Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumes.

Authors:  Isaiah Kletenik; Enrique Alvarez; Justin M Honce; Brooke Valdez; Timothy L Vollmer; Luis D Medina
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-02-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.